Let’s Talk Respiratory is an educational platform of supportive resources, materials and the latest CPD learning in respiratory care, initiated and funded by Teva UK Limited. Due to the varied breadth and nature of topics on Let’s Talk Respiratory, drug classes and guidance related to Teva’s products may be mentioned. Adverse events reporting and links to relevant prescribing information can be found at the bottom of the page.

About Teva

Teva’s mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections or simply improving overall health.

We are committed to partnering with the UK respiratory community to deliver solutions that will bring efficient and sustainable quality care to the NHS.

We’re here to help support and assist healthcare professionals for the benefit of patients living with asthma, severe asthma, COPD and cystic fibrosis. In addition to developing our speciality medicines for these conditions, we offer information and education services to improve patient care and self-management. 

By  investing in relevant and trustworthy education, Let’s Talk Respiratory aims not only to inform patients but also to support and upskill healthcare professionals to improve understanding and enhance patient care from diagnosis to management across all care settings.

Approval code: RESP-GB-00559
Date of preparation: June 2022